Synthesis and biological evaluation of Combretastatin A-4 derivatives containing a 3'-O-substituted carbonic ether moiety as potential antitumor agents

Chemistry Central Journal

Volumn 7, Issue 1, 2013, Pages

  Ma, Mingyi ^a   Sun, Longru ^a   Lou, Hongxiang ^a   Ji, Mei ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Antitumor activity; Apoptosis; Cell cycle arrest; Combretastatin A 4; Synthesis; WST 1

Indexed keywords

EID: 84889002294     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-7-179     Document Type: Article

References (21)

1. Pettit GR, Singh SB, Hamel E, Lin CM, Alberts DS, Garcia-Kendall D. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatinA-4. Experientia 1989, 45:209-211.
2. Patterson DM, Rustin GJS. Vascular damaging agents. Clin Oncol 2007, 19:443-456.
3. Lippert JW. Vascular disrupting agents. Bioorg Med Chem 2007, 15:605-615.
4. Hinnen P, Eskens F. Vascular disrupting agents in clinical development. Brit J Cancer 2007, 96:1159-1165.
5. Chang JY, Hsieh HP, Chang CY, Hsu KS, Chiang YF, Chen CM, Kuo CC, Liou JP. 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents. J Med Chem 2006, 49:6656-6659.
6. Lawrence NJ, Ghani FA, Hepworth LA, Hadfield JA, McGown AT, Pritchard RG. The synthesis of (E) and (Z)-combretastatins A-4 and a phenanthrene from Combretum caffrum. Synthesis 1999, 9:1656-1660.
7. Liou JP, Chang JY, Kuo FM, Chang CW, Tseng HY, Wang CC, Yang YN, Chang JY, Lee SJ, Hsieh HP. Concise synthesis and structure -activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents. J Med Chem 2004, 47:4247-4257.
8. Liou JP, Chang JY, Chang CW, Chang CY, Mahindroo N, Kuo FM, Hsieh HP. Synthesis and structure-activity relationships of 3-amino-benzophenones as antimitotic agents. J Med Chem 2004, 47:2897-2905.
9. Liou JP, Chang CW, Song JS, Yang YN, Yeh CF, Tseng HY, Lo YK, Chang YL, Chang CM, Hsieh HP. Synthesis and structure-activity relationship of 2-aminoben-zophenone derivatives as antimitotic agents. J Med Chem 2002, 45:2556-2562.
10. Woods JA, Hadfield JA, Pettit GR, Fox BW, McGown AT. The interaction with tubulin of a series of stilbenes based on combretastatinA-4. Brit J Cancer 1995, 71:705-711.
11. Lawrence NJ, Hepworth LA, Rennison D, McGown AT, Hadfield JA. Synthesis and anticancer activity of fluorinated analogues of combretastatin A-4. J Fluorine Chem 2003, 123:101-108.
12. Kong Y, Grembecka J, Edler MC, Hamel E, Mooberry SL, Sabat M, Rieger J, Brown ML. Structure-based discovery of a boronic acid bioisostere of combretastatin A-4. Chem Biol 2005, 12:1007-1014.
13. Pettit GR, Rhodes MR, Herald DL, Hamel E, Schmidt JM, Pettit RK. Antineoplastic agents: 445: synthesis and evaluation of structural modifications of (Z)-and (E)-combretastatin A-4. J Med Chem 2005, 48:4087-4099.
14. Chaplin DJ, Horsman MR, Siemann DW. Current development status of small-molecule vascular disrupting agents. Curr Opin Investig Drugs 2006, 7:522-528.
15. Kamal A, Mallareddy A, Ramaiah MJ, Pushpavalli SNCVL, Suresh P, Kishor C, Murty JNSRC, Rao NS, Ghosh S, Addlagatta A, Pal-Bhadra M. Synthesis and biological evaluation of combretastatin-amidobenzothiazole conjugates as potential anticancer agents. Eur J Med Chem 2012, 56:166-178.
16. Liu YQ, Li XJ, Zhao CY, Nan X, Tian J, Morris-Natschke SL, Zhang ZJ, Yang XM, Yang L, Li LH, Zhou XW, Lee KH. Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents. Bioorg Med Chem 2013, 21:1248-1256.
17. Pettit GR, Singh SB, Boyd MR, Hamel E, Pettit RK, Schmidt JM, Hogan F. Antineoplastic agents: 291: isolation and synthesis of combretastatins A-4, A-5, and A-6. J Med Chem 1995, 38:1666-1672.
18. Gaukroger K, Hadfield JA, Hepworth LA, Lawrence NJ, McGown AT. Novel syntheses of cis and trans isomers of combretastatin A-4. J Org Chem 2001, 66:8135-8138.
19. Ngamwongsatit P, Banada PP, Panbangred W, Bhunia AK. WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line. J Microbiol Meth 2008, 73:211-215.
20. Nandy P, Banerjee S, Gao H, Hui MBV, Lien EJ. Quantitative structure-activity relationship analysis of combretastatins: a class of novel antimitotic agents. Pharm Res 1991, 8:776-781.
21. Gambari R, Terada M, Bank A, Rifkind RA, Marks PA. Synthesis of globin mRNA in relation to the cell cycle during induced murine erythroleukemia differentiation. Proc Natl Acad Sci 1978, 75:3801-3804.